These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31710579)

  • 1. Evaluation of meningococcal vaccination policies among colleges and universities - United States, 2017.
    Oliver SE; Patton ME; Hoban M; Leino V; Mbaeyi SA; Hariri S; MacNeil JR
    J Am Coll Health; 2021 Jul; 69(5):554-559. PubMed ID: 31710579
    [No Abstract]   [Full Text] [Related]  

  • 2. Serogroup B meningococcal vaccination practice patterns on college campuses.
    Haimowitz R; Torres R; Caleb S; Thompson D; Smith A; Ciotoli C; Dannenbaum M; Fu LY
    Vaccine; 2020 Oct; 38(46):7350-7356. PubMed ID: 33010977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from mass vaccination response to meningococcal B outbreaks at US universities.
    Alderfer J; Isturiz RE; Srivastava A
    Postgrad Med; 2020 Sep; 132(7):614-623. PubMed ID: 32476532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease.
    La EM; Talbird SE; Kanadanian KV; Huang L; Fain J; Srivastava A
    Hum Vaccin Immunother; 2019; 15(4):978-986. PubMed ID: 30526279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
    Marjuki H; Chang HY; Topaz N; Whaley MJ; Vuong J; Chen A; Jenkins LT; Hu F; Schmink S; Retchless AC; Thomas JD; Acosta AM; McNamara LA; Soeters HM; Mbaeyi S; Wang X
    mBio; 2021 May; 12(3):. PubMed ID: 34006659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.
    Soeters HM; McNamara LA; Blain AE; Whaley M; MacNeil JR; Hariri S; Mbaeyi SA;
    Emerg Infect Dis; 2019 Mar; 25(3):434-440. PubMed ID: 30789140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of regional disparities on the availability of meningococcal vaccines in the US.
    Schley K; Jodar E; Presa JV; Willis SJ; Prener CG
    BMC Public Health; 2024 Jul; 24(1):1771. PubMed ID: 38961431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations.
    Huang L; Goren A; Lee LK; Li VW; Dempsey A; Srivastava A
    Hum Vaccin Immunother; 2020 Apr; 16(4):933-944. PubMed ID: 31634035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
    Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L
    BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
    Basta NE; Becker AB; Li Q; Nederhoff D
    Vaccine; 2019 Jan; 37(4):670-676. PubMed ID: 30587431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States Physicians' Knowledge, Attitudes, and Practices Regarding Meningococcal Vaccination for Healthy Adolescents and Young Adults.
    Herrera-Restrepo O; Bunniran S; Mond T; Davenport E; Wang J; Sweeney C; Marshall GS
    J Adolesc Health; 2024 Jun; 74(6):1131-1138. PubMed ID: 38363244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring meningococcal serogroup B vaccination conversations under shared clinical decision-making in the US.
    Herrera-Restrepo O; Clements DE; Hebert ZN; McCracken C
    Curr Med Res Opin; 2024 Jul; 40(7):1253-1263. PubMed ID: 38860982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.
    Marshall GS; Dempsey AF; Srivastava A; Isturiz RE
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):244-247. PubMed ID: 31077326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.
    Burman C; Alderfer J; Snow VT
    J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Factors Affecting University A Students' Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine.
    Breakwell L; Vogt TM; Fleming D; Ferris M; Briere E; Cohn A; Liang JL
    J Adolesc Health; 2016 Oct; 59(4):457-64. PubMed ID: 27523976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation Experience With Meningococcal Serogroup B Vaccines in the United States: Impact of a Nonroutine Recommendation.
    Fergie J; Howard A; Huang L; Srivastava A
    Pediatr Infect Dis J; 2021 Mar; 40(3):269-275. PubMed ID: 33565815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis.
    Packnett ER; Zimmerman NM; Novy P; Morgan LC; Chime N; Ghaswalla P
    Hum Vaccin Immunother; 2023 Dec; 19(1):2165382. PubMed ID: 36715008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not.
    Alderfer JT; Moran MM; Srivastava A; Isturiz RE
    Postgrad Med; 2019 Nov; 131(8):551-554. PubMed ID: 31575310
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016.
    McNamara LA; Thomas JD; MacNeil J; Chang HY; Day M; Fisher E; Martin S; Poissant T; Schmink SE; Steward-Clark E; Jenkins LT; Wang X; Acosta A;
    J Infect Dis; 2017 Nov; 216(9):1130-1140. PubMed ID: 28968661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
    Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
    BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.